Program Committee

Co-Chairs

Marcin Czech
Marcin Czech, PhD, MD, MBA
Professor, Head, Department of Pharmacoeconomics, Institute of Mother and Child, Course Director, Business School, Warsaw University of Technology, President of ISPOR Poland Chapter, Warsaw, Poland

Guido Rasi
Guido Rasi, MD
Full Professor of Microbiology, Rome University Tor Vergata, Chairman of Clinical Trial Center, Gemelli Polyclinic, Former Executive Director, European Medicines Agency, Rome Italy



Lotte Steuten
Lotte Steuten, PhD
Vice President & Head of Consulting, OHE, Honorary Visiting Professor at City, University of London, London, United Kingdom


Members

Bryan Bennett, PhD 
WWHEOR PRO Lead, Bristol Meyers-Squibb, England, United Kingdom


Laura McCullagh, PhD

Head of Research, Chief I Pharmacist, National Centre for Pharmacoeconomics Ireland (NCPE), Dublin, Ireland


Bill Byrom, PhD
Vice President, Product Strategy and Innovation, Signant Health, England, United Kingdom


Carme Pinyol, MSc, PhD, MD
Head, Pricing and Market Access Southern Europe, Pierre Fabre, Catalonia, Spain


Fleur Chandler, MSc
Head, Market Access UK and Ireland, Sanofi, England, United Kingdom


Thomas Rapp, PhD
Associate Professor, Université de Paris, Paris, France


Oriana Ciani, MSc, PhD
Associate Professor of Practice, SDA Bocconi School of Management, Milan, Italy


Edit Remak, MSc, PhD
Partner, Director, Health Economics, Visible Analytics, Budapest, Hungary


Isaac Corro Ramos, MSc
Scientific Researcher, Institute for Medical Technology Assessment, The Netherlands


Filipa Sampaio, MSc, PhD
Postdoctoral Fellow, Health Economics, Uppsala University, Uppsala, Sweden


David Epstein, PhD
Associate Professor, Department of Applied Economics, University of Granada, Granada, Spain


Vanessa Schaub, PhD
Global Access Health Systems Strategy Lead HTA & Reimbursement, F. Hoffmann La Roche, Basel, Switzerland


Edith Frenoy
Director, Public Policy, Strategic Advocacy Lead, Merck, Brussels, Belgium


Praveen Thokala, MASc, PhD
Senior Research Fellow, School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, United Kingdom


Iñaki Imaz-Iglesia, MD, PhD, MPH
Senior Researcher, Instituto de Salud Carlos III (AETS-ISCIII), Madrid, Spain


Mirjami Tran Minh
Scientific Communications and Public Affairs Specialist, Cancer IO Project, University of Helsinki, Helsinki, Finland


Pall Jonsson, PhD
Programme Director for Data and Analytics, Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE), Manchester, United Kingdom


Nicky Welton, PhD
Professor, Statistical and Health Economic Modelling, Director, NICE Guidelines Technical Support Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom


Saskia Knies, PhD
Senior Advisor, Cost-Effectiveness and Personalised Medicine, Coordinator, Research Network HTA National Health Care Institute, The Netherlands


Sorrel Wolowacz, PhD
Head, EU Health Economics RTI Health Solutions, Manchester, United Kingdom


Amr Makady, PharmD, PhD
Health Economics and Market Access Manager, Johnson & Johnson, The Netherlands


Beth Woods, BA, MSc
Senior Research Fellow, TEEHTA, Centre for Health Economics, University of York, York, United Kingdom